0       0

29th Annual North American Cystic Fibrosis Conference


S09: CFTR-NT: Developing Co-therapies to Modulate CFTR


Oct 9, 2015 10:30am ‐ Oct 9, 2015 12:20pm

Standard: $49.99

Description

This session will highlight the issues around co-therapies from the clinical to the development.

Educational Objectives:

  1. Discuss the need for co-therapies in CF for different combinations of CFTR mutations & the benefits & disadvantages of co-therapies.
  2. Analyze how to screen for additive/synergistic drugs.
  3. Demonstrate how to assess benefit of CF co-therapies.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content